TIG Advisors LLC’s Tourmaline Bio TRML Stock Holding History

TIG Advisors LLC’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-619,763	Closed	-$29.6M	–	110
2025 Q3	$29.6M	Buy	+619,763	New	+$17.2M	1.76%	17

TIG Advisors LLC's TRML Position: Q4 2025 in Review

TIG Advisors LLC sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 619,763 shares — an estimated $29.6M sold.

TIG Advisors LLC first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $29.6M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

TIG Advisors LLC reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
TIG Advisors LLC sold 619,763 Tourmaline Bio shares in Q4 2025, an estimated $29.6M.
TIG Advisors LLC first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
TIG Advisors LLC's Tourmaline Bio position peaked at $29.6M in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on TIG Advisors LLC's 13F filing for Q4 2025, filed 17 Feb 2026.